Valiant Laboratories

92.11
-2.80
(-2.95%)
Market Cap
400.22 Cr
EPS
0.13
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
157.49
52 Week Low
75.20
PB Ratio
1.80
Debt to Equity
0.41
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,740.00
#1 4,17,484.28
35.93
#1 49,887.20
12.06
#1 9,648
13.77
50.33
5,950.00
1,57,953.81
76.53
8,184.00
0.89
1,600
#1 64.53
52.20
1,480.50
1,19,567.39
24.07
26,520.70
14.17
4,155
47.38
46.85
3,119.80
1,05,588.21
57.85
10,785.70
11.59
1,656
13.54
44.66
2,415.40
99,654.22
49.19
10,615.60
19.57
1,942
-16.38
49.28
1,145.40
95,578.52
#1 17.85
28,905.40
12.36
5,578
1.69
45.30
2,024.30
92,417.58
32.06
20,141.50
#1 19.94
1,936
38.82
47.99
876.25
88,171.25
19.35
19,831.50
13.82
3,831
29.92
48.40
1,150.00
66,792.19
19.08
29,559.20
17.55
3,169
-10.04
46.30
29,955.00
63,652.28
47.81
6,097.20
10.80
1,201
16.01
48.10
Growth Rate
Revenue Growth
-43.42 %
Net Income Growth
-98.97 %
Cash Flow Change
-96.63 %
ROE
-99.55 %
ROCE
-100.93 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
84
72
92
54
63
42
33
22
25
37
Expenses
79
61
81
48
61
47
35
21
28
35
EBITDA
4
11
10
6
2
-5
-2
0
-3
2
Operating Profit %
5 %
14 %
10 %
7 %
-2 %
-16 %
-15 %
-13 %
-31 %
2 %
Depreciation
0
0
0
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
4
10
10
6
1
-5
-3
-0
-4
2
Tax
1
3
2
2
0
-2
-1
0
1
-1
Net Profit
3
8
8
4
1
-4
-1
-1
-5
2
EPS in ₹
1.65
4.70
2.41
1.31
0.24
-0.81
-0.33
-0.13
-1.09
0.54

Balance Sheet

Balance Sheet
2023
2024
Total Assets
213
343
Fixed Assets
48
50
Current Assets
151
226
Capital Work in Progress
1
43
Investments
34
38
Other Assets
130
212
Total Liabilities
213
343
Current Liabilities
51
29
Non Current Liabilities
62
77
Total Equity
101
237
Reserve & Surplus
68
193
Share Capital
33
44

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
-0
11
Investing Activities
-55
-144
Operating Activities
56
2
Financing Activities
-1
152

Share Holding

% Holding
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
0.00 %
0.00 %
0.00 %
3.48 %
1.89 %
0.00 %
0.00 %
0.64 %
DIIs
3.89 %
0.04 %
0.02 %
0.03 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.49 %
12.49 %
13.36 %
15.16 %
16.09 %
17.30 %
17.55 %
16.28 %
Others
8.68 %
12.53 %
11.68 %
6.39 %
7.07 %
7.76 %
7.51 %
8.13 %
No of Share Holders
37,434
37,434
15,821
14,914
14,249
15,189
15,692
15,036

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 100.45 106.95
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 118.45 114.20
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2024 142.65 123.85

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Integrated Filing (Financial)Feb 07, 2025
Authorised Persons For Determining / Disclosing Material Events / Information.Feb 07, 2025
Financial Results For The Quarter Ended December 31 2024.Feb 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated February 07 2025.Feb 07, 2025
Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024.Jan 31, 2025
Integrated Filing (Governance)Jan 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Statement Of Deviation For The Quarter Ended September 30, 2024Nov 13, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 13, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 12, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 12, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 12, 2024
Financial Results For The Quarter Ended September 30, 2024Nov 12, 2024
Board Meeting Outcome for Outcome Of The Board MeetingNov 12, 2024
Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Announcement Under Regulation 30 Of SEBI (LODR), 2015Oct 04, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-Credit RatingAug 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2024
Statement Of Deviation & VariationAug 14, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Financial Results For The Quarter Ended June 30, 2024Aug 12, 2024
Board Meeting Outcome for Outcome Of The Board MeetingAug 12, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 09, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 09, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2024
Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Quarter Ended June 30, 2024Aug 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2024
Reg. 34 (1) Annual Report.Jul 17, 2024
Shareholders Meeting To Be Held On August 8, 2024.Jul 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 13, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Closure of Trading WindowJun 26, 2024
Intimation Under Regulation 30 Of SEBI (LODR), 2015.Jun 21, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2024
Statement Of Deviation & Variation For Quarter Ended March 31, 2024.May 14, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 14, 2024
Re-Appointment Of Cost Auditor, Internal Auditor And Secretarial AuditorMay 14, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 14, 2024

Technical Indicators

RSI(14)
Neutral
48.61
ATR(14)
Less Volatile
5.58
STOCH(9,6)
Neutral
29.32
STOCH RSI(14)
Oversold
6.37
MACD(12,26)
Bearish
-0.69
ADX(14)
Weak Trend
20.21
UO(9)
Bearish
54.46
ROC(12)
Downtrend And Accelerating
-5.36
WillR(14)
Oversold
-87.13